Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-079787

Options or other derivatives

  • Director acquired 179,785 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Noble James Director 2020-07-01 Grant or award · Option to purchase Ordinary Shares +179,785 179,785 D
Loading xslF345X03/a4.xml…